Thus, Se shows potential therapeutic benefits in modulating AD pathology by inhibiting Aβ and Tau abnormalities and enhancing neuroprotection, while, selenoproteins can affect microglial activity and inhibit ferroptosis to improve cognitive function. Here, MAPT is linked to Alzheimer disease.